Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
58.3M
-
Shares change
-
-343K
-
Total reported value, excl. options
-
$5.66B
-
Value change
-
+$5.99M
-
Put/Call ratio
-
0.91
-
Number of buys
-
124
-
Number of sells
-
-102
-
Price
-
$97.08
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q2 2021
274 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q2 2021.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.3M shares
.
Largest 10 shareholders include Capital World Investors (6.06M shares), Capital International Investors (5.64M shares), BlackRock Inc. (4.69M shares), MARSHALL WACE, LLP (2.73M shares), STIFEL FINANCIAL CORP (2.57M shares), ORACLE INVESTMENT MANAGEMENT INC (2.08M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.99M shares), JPMORGAN CHASE & CO (1.75M shares), STATE STREET CORP (1.48M shares), and WELLS FARGO & COMPANY/MN (1.43M shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.